Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Human monoclonal anti-phospholipid antibodies selectively bind to membrane phospholipid and beta2-glycoprotein I (beta2-GPI) on apoptotic cells
  • Publication Type:
    Journal article
  • Publication Sub Type:
  • Authors:
    Pittoni V, Ravirajan CT, Donohoe S, MacHin SJ, Lydyard PM, Isenberg DA
  • Publication date:
  • Pagination:
    533, 543
  • Journal:
    Clinical and Experimental Immunology
  • Volume:
  • Issue:
  • Print ISSN:
  • Keywords:
    ACT, AFFINITIES, affinity, analysis, Animal, antibodies, Antibodies, Antiphospholipid, Monoclonal, Antibody, Antibody Specificity, apoptosis, As, beta, BINDING, cell, Cell Membrane, CELLS, EPITOPE, Epitopes, Flow Cytometry, glycoprotein, Glycoproteins, immunology, in vivo, in-vivo, interaction, Lipids, MECHANISM, medicine, membrane, Membrane Lipids, mice, PATHOLOGICAL IMPLICATIONS, Patient, patients, Phospholipids, Rheumatology, SPECIFICITIES, SPECIFICITY, Support, Non-U.S.Gov't, Syndrome, U937 Cells, UK
  • Addresses:
    Centre for Rheumatology/Bloomsbury Rheumatology Unit, Department of Medicine and Department of Haematology, University College London, London, UK
  • Notes:
    UI - 20156200 LA - eng RN - 0 (Antibodies, Antiphospholipid) RN - 0 (Antibodies, Monoclonal) RN - 0 (Glycoproteins) RN - 0 (Membrane Lipids) RN - 0 (Phospholipids) RN - 0 (beta 2-glycoprotein I) PT - Journal Article DA - 20000424 IS - 0009-9104 SB - IM CY - ENGLAND JC - DD7
The ability of an anti-phospholipid (LJ1) and an anti-beta2-GPI (RSP- 57) human MoAb to bind to apoptotic but not viable cells was demonstrated in this study. Both MoAbs were derived from patients with systemic lupus erythematosus and anti-phospholipid antibody syndrome. The parallel analysis of the specificity and affinity of four anti- phospholipid human MoAbs suggests that the binding of LJ1 MoAb to apoptotic cells is a specific property of this MoAb. RSP-57 MoAb recognizes apoptotic cells through beta2-GPI which becomes available for binding after the interaction with negatively charged phospholipids. This observation provides evidence that the binding of human anti-phospholipid antibodies to apoptotic cells occurs in both a beta2-GPI-dependent and independent way and involves a restricted group of epitopes. The finding that LJ1 and RSP-57 MoAbs bind apoptotic cells underlines the property of these MoAbs to act as cell membrane markers of apoptosis. Major pathological implications derive from the observation that LJ1 and RSP-57 MoAbs recognize epitopes expressed on 'early' apoptotic cells. The interference with the in vivo clearance and processing of apoptotic cells is a potential pathogenic mechanism of these antibodies
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Div of Infection & Immunity
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by